Response to Brigatinib Targeted Therapy in Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 19 Deletion, T790M, and cis-C797S Triple Mutations: A Case Report

Epidermal growth factor receptor (EGFR) triple mutations with exon 19 deletion (del19), T790M, and cis-C797S (del19/T790M/cis-C797S mutations) frequently occur in patients with non-small cell lung cancer (NSCLC), while progression to frontline EGFR-tyrosine kinase inhibitors (TKIs) and osimertinib w...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zi-Wei, Lin, Gigin, Shih, Hsuan-Jen, Wu, Chiao-En
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820100/
https://www.ncbi.nlm.nih.gov/pubmed/36614045
http://dx.doi.org/10.3390/ijms24010602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820100/
https://www.ncbi.nlm.nih.gov/pubmed/36614045
http://dx.doi.org/10.3390/ijms24010602

Ejemplares similares